ASM Microbe 2026
June 4-7, 2026 – Washington, DC, USA
ADLM 2026
July 26-30, 2026 – Anaheim, CA, USA

Protein Glycosylation

Protein glycosylation involves the covalent attachment of complex sugar molecules (called glycans) to proteins. It is a highly abundant and particularly complex type of protein post-translational modification (PTM). Through complex and precise glycosylation modifications of proteins, abundant protein types can be produced within cells. This PTM impacts protein structure, stability, and function, and is critical for a wide range of biological processes, including intracellular/intercellular signal transduction, immune regulation, and protein stability maintenance.

Schematic diagram of phosphorylation and dephosphorylation.Figure 1. Specific roles of glycosylation in regulating protein functions.
(Source: Schjoldager, K. T. et al., 2020)

What is Protein Glycosylation?

Glycosylation is the reaction in which a carbohydrate (i.e., a glycosyl donor) is attached to a hydroxyl or other functional group of another molecule (a glycosyl acceptor) to form a glycoconjugate. It is a crucial function occurring in the biosynthetic-secretory pathway, specifically in the endoplasmic reticulum (ER) and Golgi apparatus. This modification is widespread, with approximately half of all proteins expressed in a cell undergoing glycosylation. It affects various types of proteins, such as soluble and membrane-bound proteins expressed in the ER, including secreted proteins, surface receptors, ligands, and organelle-resident proteins. Furthermore, glycosylation also occurs on proteins trafficked from the Golgi to the cytoplasm, and lipids and proteoglycans, significantly expanding the range of substrates for this PTM.

Browse all our Glycoprotein products

Glycosylation offers an unparalleled level of diversity to the proteome. The cell can generate a vast array of glycoproteins with unique properties and functions because various aspects of glycosylation can be modified, including:

  • Glycosidic bond—the site of glycan (oligosaccharide) binding
  • Glycan length—short- or long-chain oligosaccharides
  • Glycan composition—the types of sugars that are linked to a given protein
  • Glycan structure—unbranched or branched chains of sugars

This extraordinary diversity plays a critical role in numerous biological processes and contributes to the complexity of living organisms.

Mechanisms of Protein Glycosylation

There are several mechanisms by which protein glycosylation can occur, although most share several common features:

  • Glycosylation, a complex enzymatic process, involves the attachment of sugar molecules to proteins. It is distinct from glycation, which is a non-enzymatic process. Glycosylation is considered the most intricate PTM due to its numerous enzymatic steps.
  • In glycosylation, an activated nucleotide sugar often serves as the donor molecule, providing the necessary energy and chemical group for the glycosylation reaction.
  • The process of glycosylation is non-templated, meaning it is not guided by a template molecule such as DNA in transcription or mRNA in protein translation. Instead, the cell relies on specific enzymes localized in different compartments, such as the endoplasmic reticulum and Golgi apparatus, to carry out glycosylation at specific sites on proteins.

Types of Protein Glycosylation

Protein glycosylation encompasses various types, each with distinct characteristics and functions. Among them, N- and O-glycosylation are the most commonly detected types of glycosylation.

The two most common types of glycosylation.Figure 2. The two most common types of glycosylation.
(Source: Ma, B. et al., 2020)

  • N-linked Glycosylation
    • N-linked glycosylation is a highly conserved process that occurs in the endoplasmic reticulum (ER) and Golgi apparatus. It involves the attachment of glycans to the amide nitrogen of asparagine residues (N) within the consensus sequence Asn-X-Ser/Thr, where X can be any amino acid except proline.
    • Biological functions: N-linked glycosylation is critical for protein folding, quality control, and cellular trafficking. It is mediated by a complex enzymatic pathway that requires the participation of various glycosyltransferases and glycosidases.
      Learn more about N-Glycan Analysis Kit
  • O-linked Glycosylation
    • O-linked glycosylation involves the attachment of glycans to the hydroxyl group of serine (S) or threonine (T) residues in proteins.
    • Biological functions: O-linked glycosylation has been implicated in a variety of cellular processes, including cell signaling, protein stability, and the pathogenesis of diseases such as cancer, inflammation, and autoimmune diseases.
  • Other Types of Glycosylation
    Additional types of glycosylation include phosphoserine glycosylation, C-mannosylation, chemical glycosylation, and formation of GPI anchors (glypiation). Each of these types has unique characteristics and impacts protein structure and function in specific ways.
    • Phosphoserine glycosylation involves the attachment of glycans to serine residues that have been phosphorylated.
    • Glycosylphosphatidylinositol (GPI) anchors are specialized lipid structures that serve as glycan carriers for attaching proteins to the outer surface of cell membranes.
    • C-mannosylation refers to the attachment of a mannose sugar to the carbon atom of a tryptophan residue in a protein.
    • Chemical glycosylation is a synthetic approach to introducing glycans onto proteins through chemical reactions.

Applications of Protein Glycosylation Research

An in-depth study of protein glycosylation types, sites, and content changes in cells is of great significance in many fields such as biomedicine, biotechnology, and drug development. Some key applications include:

  • Biomarker discovery
    Altered glycosylation patterns on proteins have shown promise as diagnostic and prognostic biomarkers for various diseases. By analyzing glycoprotein profiles, researchers can identify glycoprotein markers that indicate disease progression or therapeutic response. Currently, more than ten glycoprotein serological markers have been discovered for the clinical diagnosis of cancer.
  • Disease research
    Aberrant protein glycosylation has been linked to various diseases, including cancer, autoimmune disorders, and congenital disorders of glycosylation (CDGs). Changes in glycan structures on tumor-associated antigens can contribute to immune evasion by cancer cells. Monitoring glycosylation patterns can aid in disease diagnosis, prognosis, and therapeutic interventions.
  • Targeted therapeutics
    In cancer immunotherapy, glycoproteins and glycopeptides are involved and play important roles in anti-tumor-specific sugar chain vaccines, antibody suppression immunotherapy, ADC drug targeted therapy, CAR-T cell therapy, and DC cell targeted therapy. Understanding the impact of glycosylation on drug function can lead to the design of more effective and targeted treatments.
  • Glycoengineering
    Glycoengineering involves modifying glycan structures on proteins to enhance their stability, functionality, or immunogenicity. This approach has applications in the development of improved biopharmaceuticals, enzymes, and industrial enzymes.

Conclusion

Protein glycosylation is a fascinating area of research with profound implications in biology and medicine. The attachment of glycans to proteins influences their structure, function, and cellular interactions. Understanding the mechanisms and types of protein glycosylation is crucial for deciphering its role in health and disease. With the support of cutting-edge products and services provided by Creative Diagnostics, researchers can advance their understanding of protein glycosylation and harness its potential for therapeutic interventions and diagnostic applications.

References

  1. Schjoldager K T, et al. Global view of human protein glycosylation pathways and functions. Nature Reviews Molecular Cell Biology. 2020, 21(12): 729-749.
  2. Ma B, et al. Protein glycoengineering: An approach for improving protein properties. Frontiers in Chemistry. 2020, 8: 622.
  3. Pinho S S, Reis C A. Glycosylation in cancer: mechanisms and clinical implications. Nature Reviews Cancer. 2015, 15(9): 540-555.

For research use only, not for use in diagnostic procedures.

Protein Glycosylation Antibodies

TargetCat. No.Product NameHostIsotypeApplication
ANDV GlycoproteinDPABH-00008Anti-ANDV Glycoprotein Polyclonal antibodyRabbitIgGELISAInquiry
DPAB-L20055Anti-ANDV Glycoprotein Polyclonal antibodyRabbitIgGELISAInquiry
Cedar virus GlycoproteinCABT-NS1138Mouse Anti-Cedar virus Glycoprotein Monoclonal Antibody, clone 11D5MouseIgG1IPInquiry
CABT-NS1139Human Anti-Cedar virus Glycoprotein Monoclonal Antibody, clone11D5HumanIgG1IPInquiry
CABT-NS1140Rabbit Anti-Cedar virus Glycoprotein Monoclonal Antibody, clone 14F3RabbitIgGIP, WBInquiry
CMV Glycoprotein BDMABT-Z60792Anti-Cytomegalovirus Glycoprotein B Monoclonal antibody, Clone EJ30MouseIgG1ICC, IF, WBInquiry
DMABT-Z60796Anti-Cytomegalovirus Glycoprotein B Monoclonal antibody, Clone JEOX49MouseIgG2aELISA, ICC, IF, IHC-Fr, NeutInquiry
DMABT-Z61002Anti-Cytomegalovirus Glycoprotein B Monoclonal antibody, Clone 4H24MouseIgG1, κWB, ELISA, ICC, IFInquiry
CABT-L2443Anti-CMV glycoprotein B chimeric monoclonal antibody, clone 0G4B5MouseIgGELISAInquiry
CABT-L2444Anti-CMV glycoprotein B chimeric monoclonal antibody, clone 9B4B4MouseIgMELISAInquiry
DPATB-H83496Anti-Cytomegalovirus Glycoprotein B Polyclonal antibodyGoatIgGICC, IF, WBInquiry
DPATB-H83501Anti-Cytomegalovirus Glycoprotein B Polyclonal antibodyGoatIgGICC, IF, ELISA, WB, IHC-FrInquiry
DPATB-H83500Anti-Cytomegalovirus Glycoprotein B Polyclonal antibody[FITC]GoatIgGICC, IFInquiry
DPATB-H83458Anti-Cytomegalovirus Glycoprotein B Polyclonal antibody[HRP]GoatIgGWB, ICCInquiry
DMABT-Z60847Anti-Cytomegalovirus Glycoprotein B Monoclonal antibody, Clone JEOX49[FITC]MouseIgG2aICC, IFInquiry
CABT-NS1704Mouse Anti-CMV Glycoprotein B Monoclonal Antibody, clone 22C21E4F5MouseIgG1WB, ELISAInquiry
CMV Glycoprotein HDMABT-Z60756Anti-Cytomegalovirus Glycoprotein H Monoclonal antibody, Clone 3.D.336MouseIgG1ELISA, ICC, IFInquiry
CABT-B8686Anti-CMV gp gH monoclonal antibody, clone 972MouseIgG1IF, ELISAInquiry
DCABY-038Anti-Cytomegalovirus Glycoprotein H Monoclonal antibody, Clone IDNW27 (62D2)MouseIgG1IHC-Fr, ELISA, FuncS, IF, IPInquiry
DCABY-806Anti-Cytomegalovirus Glycoprotein H Monoclonal antibody, Clone 972MouseIgG1ELISA, IF, IHC-PInquiry
CrPV glycoprotein 1DPAB-DC4137Anti-CrPV Glycoprotein 1 Polyclonal antibodyRabbitIgGWB, ELISAInquiry
CsA glycoproteinDMAB9414Anti-Bacteria Glycoprotein Monoclonal antibodyMouseIgG1WBInquiry
DMAB9415Anti-Bacteria Glycoprotein Monoclonal antibodyMouseIgG1WBInquiry
DMAB9424Anti-Bacteria CsA Monoclonal antibodyMouseIgG1WBInquiry
DMAB9425Anti-Bacteria CsA Monoclonal antibodyMouseIgG1WBInquiry
DMAB9429Anti-Bacteria CsA Monoclonal antibodyMouseIgG1WBInquiry
CSFV Structural GlycoproteinCABT-BL8758Anti-CSFV Structural Glycoprotein monoclonal antibody, clone 1D2MouseIgG2aELISA, WBInquiry
CABT-BL8759Anti-CSFV Structural Glycoprotein monoclonal antibody, clone 1D3MouseIgG1ELISA, WBInquiry
CABT-BL8760Anti-CSFV Structural Glycoprotein monoclonal antibody, clone 1D4MouseIgG1ELISA, WBInquiry
DENV E glycoproteinDCABH-8862Anti-DENV E glycoprotein Monoclonal antibody, Clone EF3MouseIgG2aICC/IF, ELISAInquiry
DCABH-8855Anti-DENV E glycoprotein Monoclonal antibody, Clone EF2MouseIgG2bICC/IF, ELISA, DotInquiry
DENV PrM glycoproteinDMABT-Z60909Anti-DENV PrM glycoprotein Monoclonal antibody, Clone FO3MouseIgG1, κICC, IF, WB, ELISAInquiry
EHV type 1 Glycoprotein 2DPAB-DC4212Anti-EHV-1 Equine herpesVirus type 1 gp2 (C-terminal) polyclonal antibodyRabbitIgGWB, ELISAInquiry
EHV1 glycoprotein gp2DPATB-H81429Anti-EHV Glycoprotein 2 Polyclonal antibodyRabbitIgGWB, ELISAInquiry
FeLV glycoprotein 70DMABT-Z60765Anti-FeLV Glycoprotein 70 Monoclonal antibody, Clone DFK824MouseIgG1ELISA, ICC, IFInquiry
DCABY-268Anti-FeLV Glycoprotein 70 Monoclonal antibody, Clone D22E9MouseIgG2bIHC-Fr, FC, IP, IHC-P, WBInquiry
Flavivirus E-glycoproteinDMABT-Z60926Anti-Flavivirus E glycoprotein Monoclonal antibody, Clone 4683MouseIgG2aICC, IF, ELISAInquiry
Ghana virus GlycoproteinCABT-NS1147Human Anti-Ghana virus Glycoprotein Monoclonal Antibody, clone 10C4-LYHumanIgG1IP, WB, ELISAInquiry
CABT-NS1148Mouse Anti-Ghana virus Glycoprotein Monoclonal Antibody, clone 10D5-LYMouseIgMIP, WB, ELISAInquiry
Hantavirus GlycoproteinDMAb6836Anti-Hantavirus Glycoprotein Monoclonal antibody, Clone 4G4/I3MouseIgG1ELISA, WBInquiry
DMAb6838Anti-Hantavirus Glycoprotein Monoclonal antibody, Clone 4D8/C11MouseIgG1ELISA, WBInquiry
HCoV spike glycoproteinCABT-CS868Mouse Anti-HCoV-HKU1 Spike RBD Monoclonal antibody, clone 2156MouseIgG2aICCInquiry
HeV and NiV GlycoproteinCABT-NS1156Human Anti-HeV and NiV Glycoprotein Monoclonal Antibody, clone 48D3HumanIgGIP, WBInquiry
CABT-NS1157Mouse Anti-HeV and NiV Glycoprotein Monoclonal Antibody, clone 48D3MouseIgMIP, WBInquiry
hMPV GlycoproteinCABT-B241Anti-hMPV Glycoprotein monoclonal antibody, clone 26F5I9MouseIgG2aWB, IFInquiry
HRTV Glycoprotein 1DPAB-DC4308Anti-Heartland virus G1 protein Polyclonal antibodyRabbitIgGELISAInquiry
DPAB-L20527Anti-Heartland virus Glycoprotein 1 Polyclonal antibodyRabbitIgGELISAInquiry
HRTV Glycoprotein 2DPAB-DC4309Anti-Heartland virus G2 protein Polyclonal antibodyRabbitIgGELISAInquiry
DPAB-L20528Anti-Heartland virus Glycoprotein 2 Polyclonal antibodyRabbitIgGELISAInquiry
HTLV1 Glycoprotein 46DMABT-Z60559Anti-HTLV type 1 Glycoprotein 46 Monoclonal antibody, Clone 79/7.725.3MouseIgG1RipA, WB, ELISA, ICC, IF, FCInquiry
DMABT-Z60560Anti-HTLV type 1 Glycoprotein 46 Monoclonal antibody, Clone 70/6.23.33MouseIgG1RipA, WB, ELISA, ICC, IFInquiry
DMABT-Z60561Anti-HTLV type 1 Glycoprotein 46 Monoclonal antibody, Clone 77/8E4.4.46MouseIgG1WB, RipA, ELISA, ICC, IFInquiry
HTLV2 Glycoprotein 46DMABT-Z59698Anti-HTLV type 2 Glycoprotein 46 Monoclonal antibody, Clone 85/6.20.0MouseIgG1WB, RipA, ELISA, ICC, IFInquiry
IBV Glycoprotein NBDPATB-H83571Anti-IBV Glycoprotein NB Polyclonal antibodyRabbitIgGIHC-P, WB, ELISAInquiry
JEV glycoprotein EDCABH-8861Anti-JEV E glycoprotein Monoclonal antibody, Clone KF2MouseIgG2aWB, ELISA, Dot, ICC/IFInquiry
JEV Glycoprotein NS1DMABT-Z60919Anti-JEV Glycoprotein NS1 Monoclonal antibody, Clone LP3MouseIgG3, κFC, IHC-FoFr, WB, ICC, IF, ELISAInquiry
Nuclear Pore O-Linked Glycoprotein-Nuclear Pore MarkerDMABT-Z59851Anti-Nuclear Pore O-Linked Glycoprotein-Nuclear Pore Marker monoclonal antibody, clone UN3MouseIgMBL, ICC, IF, IP, WBInquiry
P GlycoproteinDMABT-Z59858Anti-P Glycoprotein monoclonal antibody, clone 377/H6MouseIgG1, κWB, IHC-Fr, FC, ICC, IFInquiry
CABT-B776Anti-P Glycoprotein monoclonal antibody, clone D320MouseIgG2aFACS, ICC/IF, IHC, IHC-Fr, IHC-P, IP, WBInquiry
CABT-L739Rabbit Anti-P Glycoprotein monoclonal antibody, clone TO17-53RabbitIgGWB, IHCInquiry
PNS myelin glycoproteinDMAB9341Anti-Quail PNS Myelin Glycoproteins Monoclonal antibody, clone 0MouseIgG1WB, IHCInquiry
PUUV GlycoproteinDPABH-28720Anti-PUUV Glycoprotein Polyclonal antibodyRabbitIgGELISAInquiry
DPAB-L20972Anti-PUUV Glycoprotein Polyclonal antibodyRabbitIgGELISAInquiry
RESTV glycoproteinCABT-B1106Anti-RESTV GP polyclonal antibodyRabbitIgGELISA, WBInquiry
RSV F GlycoproteinCABT-B8752Anti-RSV (F protein) monoclonal antibodyMouseIgG2bELISA, LFIAInquiry
RSV F GlycoproteinCABT-L2445Anti-Human RSV F protein chimeric monoclonal antibody, clone J6C5MouseIgAELISAInquiry
CABT-L2689Human Anti-RSV pre- and postfusion conformation of HRSV F protein monoclonal antibody, clone STC26HumanIgG1, κFuncS, IFInquiry
CABT-L2690Chimeric Rabbit Anti-RSV pre- and postfusion conformation of HRSV F protein monoclonal antibody, clone STC26RabbitIgG, κFuncS, IFInquiry
CABT-L2691Human Anti-RSV pre- and postfusion conformation of HRSV F protein monoclonal antibody, clone STC27HumanIgG1, κFuncS, IFInquiry
CABT-L2692Chimeric Rabbit Anti-RSV pre- and postfusion conformation of HRSV F protein monoclonal antibody, clone STC27RabbitIgG, κFuncS, IFInquiry
CABT-L2693Human Anti-RSV pre-fusion conformation of HRSV F protein monoclonal antibody, clone STC30HumanIgG1, λFuncS, IFInquiry
CABT-L2694Chimeric Rabbit Anti-RSV pre-fusion conformation of HRSV F protein monoclonal antibody, clone STC30RabbitIgG, λFuncS, IFInquiry
CABT-L2695Human Anti-RSV pre-fusion conformation of HRSV F protein monoclonal antibody, clone STC54HumanIgG1, λFuncS, IFInquiry
CABT-L2696Chimeric Rabbit Anti-RSV pre-fusion conformation of HRSV F protein monoclonal antibody, clone STC54RabbitIgG, λFuncS, IFInquiry
DMAB-CS23147Mouse Anti-RSV (type A & B) F Protein Monoclonal antibody, clone RE01MouseIgG2aIF, ELISAInquiry
RSV Fusion GlycoproteinDMABT-Z60931Anti-RSV Fusion Glycoprotein Monoclonal antibody, Clone USX7C8MouseIgG2aELISA, WB, ICC/IF, IHC-P, IHC-FrInquiry
RSV G GlycoproteinDMABT-Z60266Anti-RSV glycoprotein monoclonal antibody, clone 0E7MouseIgG2bWB, ELISAInquiry
DMABT-Z60929Anti-RSV G Glycoprotein Monoclonal antibody, Clone USX245MouseIgG1ELISA, WB, ICC/IF, IHC-FrInquiry
DMABT-Z60930Anti-RSV Group A G Glycoprotein Monoclonal antibody, Clone USX3E4MouseIgG2aELISA, WB, ICC/IF, IHC-FrInquiry
CABT-NS1788Mouse Anti-RSV-G Monoclonal Antibody, clone 0I3H6D7MouseIgG1WB, ELISAInquiry
RSV Major GlycoproteinDPATB-H83520Anti-RSV Major Glycoprotein Polyclonal antibodyRabbitIgGWBInquiry
DPATB-H83521Anti-RSV Major Glycoprotein Polyclonal antibodyRabbitIgGWBInquiry
SNV GlycoproteinDPABH-29329Anti-SNV Sin Nombre Virus Glycoprotein 1 (N-terminal) polyclonal antibodyRabbitIgGELISAInquiry
DPAB-L20517Anti-SNV Glycoprotein Polyclonal antibodyRabbitIgGELISAInquiry
DPAB-L20518Anti-SNV Glycoprotein Polyclonal antibodyRabbitIgGELISAInquiry
DPAB-L21110Anti-SNV Glycoprotein 1 Polyclonal antibodyRabbitIgGELISAInquiry
SNV Glycoprotein 2DPABH-29330Anti-SNV Glycoprotein 2 Polyclonal antibodyRabbitIgGELISAInquiry
DPAB-L21111Anti-SNV Glycoprotein 2 Polyclonal antibodyRabbitIgGELISAInquiry
WNV M glycoproteinDPATB-H83558Anti-WNV Matrix glycoprotein Polyclonal antibodyRabbitIgGELISAInquiry
DPATB-H83559Anti-WNV Matrix glycoprotein Polyclonal antibodyMouseIgGWBInquiry
DPATB-H83562Anti-WNV Matrix glycoprotein Polyclonal antibodyRabbitIgGIHC-P, WB, ICC/IFInquiry

Protein Glycosylation Antigens

TargetCat. No.Product NameExpression SystemTag/ConjugateApplication
SFTS virus Glycoprotein G1DAG2022Recombinant SFTS virus Glycoprotein G1 (a.a. 20-452) [His]HEK293 cellsHisWB, ELISAInquiry
DAG2023Recombinant SFTS virus Glycoprotein G2 (a.a. 563-1035) [His]HEK293 cellsHisWB, ELISAInquiry
SARS-CoV-2 spike glycoproteinDAG-WT365Recombinant SARS-CoV-2 Spike protein (S) VLP [His]HEK293HisELISAInquiry
SNV GlycoproteinCDBP5517SNV GLYCOPROTEIN blocking peptideN/AUnconjugatedIBInquiry
CDBP5518SNV GLYCOPROTEIN blocking peptideN/AUnconjugatedIBInquiry
HRTV Glycoprotein 1CDBP5527HRTV GLYCOPROTEIN blocking peptideN/AUnconjugatedIBInquiry
HRTV Glycoprotein 2CDBP5528HRTV GLYCOPROTEIN blocking peptideN/AUnconjugatedIBInquiry
PUUV GlycoproteinCDBP5972PUUV GLYCOPROTEIN blocking peptideN/AUnconjugatedIBInquiry
SNV GLYCOPROTEINCDBP6110SNV GLYCOPROTEIN 1 blocking peptideN/AUnconjugatedIBInquiry
SNV Glycoprotein 2CDBP6111SNV GLYCOPROTEIN 2 blocking peptideN/AUnconjugatedIBInquiry
WNV M glycoproteinDAG-P2080WNV M glycoprotein blocking peptideN/AUnconjugatedBL, ELISAInquiry
SUDV GlycoproteinDAG-H10347SUDV Glycoprotein [His]HEK293HisN/AInquiry
DAG-H10348SUDV Glycoprotein [His]Insect cellsHisN/AInquiry
CMV Glycoprotein BDAG-WT337Recombinant CMV gB (UL55) (aa 549-645) [GST]E. coliGSTWB, ELISAInquiry
DAG-H10038CMV Glycoprotein B [Fc]HEK293 cellsFcELISAInquiry
DAG-H10040CMV Glycoprotein B [Fc]HEK293 cellsFcELISAInquiry
DAG-H10041CMV Glycoprotein B [His]HEK293 cellsHisELISAInquiry
DAG-2806CytomegalovirusE. coliUnconjugatedSDS-PAGE, WBInquiry
DAG-T1116CMV Glycoprotein B mosaicE. coliUnconjugatedN/AInquiry
DAGA-037Recombinant CMV Glycoprotein BE. coliUnconjugatedELISA, WBInquiry
DAG-H10039Recombinant Human Cytomegalovirus Glycoprotein B Protein [Flag]HEK293 cellsUnconjugatedN/AInquiry
DAG667Recombinant CMV Glycoprotein B [GST]E. coliGSTELISA, WBInquiry
DAG495Recombinant CMV Glycoprotein B [GST]E. coliGSTELISA, WBInquiry
DAG-P2590CMV Active Glycoprotein BE. coliUnconjugatedELISA, WBInquiry
DAG4719Recombinant CMV (gB) [GST]E. coliGSTELISA, WBInquiry

Protein Glycosylation ELISA Kits

TargetCat. No.Product NameSizeSpecies ReactivityApplicationDetection Sample
GlycoproteinDEIA-BJ2882Canine T-H glycoprotein ELISA Kit96TQuantitativeSerum, plasma, cell culture supernatants, body fluid and tissue homogenateInquiry
DEIABL389Chicken Alpha 1-Acid Glycoprotein ELISA Kit96TQuantitativePlasma, SerumInquiry
DEIABL392Dog Alpha 1-Acid Glycoprotein ELISA Kit96TQuantitativePlasma, SerumInquiry
DEIABL384Bovine Alpha 1-Acid Glycoprotein ELISA Kit96TQuantitativePlasma, SerumInquiry
DEIABL402Human Alpha 1-Acid Glycoprotein ELISA Kit96TQuantitativePlasma, Serum, UrineInquiry
DEIABL412Pig Alpha 1-Acid Glycoprotein ELISA Kit96TQuantitativePlasma, SerumInquiry
DEIABL413Rat Alpha 1-Acid Glycoprotein ELISA Kit96TQuantitativePlasma, Serum, UrineInquiry
DEIA-WZ131Human Zinc-Alpha-2-Glycoprotein ELISA Kit96THumanQualitativeSerum, PlasmaInquiry
DEIA-LL302Cat Alpha 1-Acid Glycoprotein (AGP) ELISA Kit96TCatQuantitativePlasma, SerumInquiry
Inquiry Basket